Cheyenne, Wyoming, June 16, 2016 (GLOBE NEWSWIRE) -- MedX Holdings, Inc. (OTC PINK: MEDH) today announced that MEDH in keeping with our Mission Statement: “To exceed any eXpectations for customer service, product pricing or market value that our customers, team members or investors expect” we are proud to announce we have entered into a Consulting Agreement with Spectrum Advanced Marketing and Dr. Robert Needham.
About Spectrum: For 21 years, SPECTRUM Advanced Markets, Inc., located in Birmingham, Alabama area, has provided C-Level Advisory, Consulting, and Coaching services to business clients in the United States and several foreign countries. Spectrum’s expertise in corporate governance, strategy, finance, franchising, cooperatives, public companies, contracts, negotiations, sales, and marketing continue to win contacts where they provide stewardship or management of current client assets well in excess of $200 Million. The firm is regularly called upon as a court appointed corporate forensic analyst in multi-million-dollar litigation cases in related industries. Spectrum’s president, Dr. Robert A. Needham, JD, PhD is a proven strategist, business administrator, and published author of numerous works in this field, including Collaborative Commonwealth.
Ms. Roberton, CEO commented: “I have had the pleasure of knowing Dr. Needham since 2011. He has worked with me in other businesses and has always brought extreme value, I am very excited to have him as a vital part of our team!”.
Dr. Needham also commented: “In the 21st century, it takes vision to compete in this agile, on-demand, and collaborative business environment. When I reviewed the strategic plans, thought leadership, and experience in medicine and pharmacy which guides MedX Holdings, Inc. and its subsidiary MedX Pharmaceuticals, Inc., I knew Spectrum's experience in the pharmacy marketplace in Alabama and elsewhere would enable them to capture over $100 Million in sales quickly.”
MedX Holdings, Inc. is a publicly trading holding company utilizing a new form of Collaborative Governance. MEDH targets the acquisitions of undervalued, turnaround medical related businesses. In addition, MedX Pharmaceuticals, a wholly-owned subsidiary of MEDH is newly emerging as dynamic distributor of an array of pharmaceutical and nutraceutical products.
For more information about MedX Holdings, Inc., call (877) 225-0243 or visit our web site www.medxholdings.com is located at 1621 Central Avenue, Cheyenne, WY, USA
Safe-Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company’s financing plans; (ii) trends affecting the company’s financial condition or results of operations; (iii) the company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company’s Forms 10-K and 10-Q filed with the SEC.